Anti-HBs responses to vaccination with a human hepatitnis B vaccine made by recombinant DNA technology in yeast

F. B. Hollinger; C. L. Troisi; P. E. Pepe

doi:10.1093/infdis/153.1.156

Anti-HBs responses to vaccination with a human hepatitnis B vaccine made by recombinant DNA technology in yeast

F. B. Hollinger, C. L. Troisi, P. E. Pepe

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	156-159
Number of pages	4
Journal	Journal of Infectious Diseases
Volume	153
Issue number	1
DOIs	https://doi.org/10.1093/infdis/153.1.156
State	Published - Jan 1986

ASJC Scopus subject areas

Immunology and Allergy
Infectious Diseases

Access to Document

10.1093/infdis/153.1.156

Cite this

@article{e3f50d7cfc6e4a46bd231e8f630a26ee,

title = "Anti-HBs responses to vaccination with a human hepatitnis B vaccine made by recombinant DNA technology in yeast",

author = "Hollinger, {F. B.} and Troisi, {C. L.} and Pepe, {P. E.}",

note = "Funding Information: This work was supported by a grant from Merck & Company, West Point, Pennsylvania. Computational assistance was provided by the CLINFO Project, funded by grant RR-00350 from the Division of Research Resources of the National Institutes of Health. Funding Information: This work was supported by the Medical Research Council. Dr. Heard was funded by a George Alwyn Research Bursary. Dr. Holland was funded by Automated Microbiology Systems Ltd.",

year = "1986",

month = jan,

doi = "10.1093/infdis/153.1.156",

language = "English (US)",

volume = "153",

pages = "156--159",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Anti-HBs responses to vaccination with a human hepatitnis B vaccine made by recombinant DNA technology in yeast

AU - Hollinger, F. B.

AU - Troisi, C. L.

AU - Pepe, P. E.

N1 - Funding Information: This work was supported by a grant from Merck & Company, West Point, Pennsylvania. Computational assistance was provided by the CLINFO Project, funded by grant RR-00350 from the Division of Research Resources of the National Institutes of Health. Funding Information: This work was supported by the Medical Research Council. Dr. Heard was funded by a George Alwyn Research Bursary. Dr. Holland was funded by Automated Microbiology Systems Ltd.

PY - 1986/1

Y1 - 1986/1

UR - http://www.scopus.com/inward/record.url?scp=0022629120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022629120&partnerID=8YFLogxK

U2 - 10.1093/infdis/153.1.156

DO - 10.1093/infdis/153.1.156

M3 - Comment/debate

C2 - 3941280

AN - SCOPUS:0022629120

SN - 0022-1899

VL - 153

SP - 156

EP - 159

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 1

ER -

Anti-HBs responses to vaccination with a human hepatitnis B vaccine made by recombinant DNA technology in yeast

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this